Complex neural circuitry requires stable connections formed by lengthy axons. To maintain these functional circuits, fast transport delivers RNAs to distal axons where they undergo local translation. However, the mechanism that enables long-distance transport of RNA granules is not yet understood. Here, we demonstrate that a complex containing RNA and the RNA-binding protein (RBP) SFPQ interacts selectively with a tetrameric kinesin containing the adaptor KLC1 and the motor KIF5A. We show that the binding of SFPQ to the KIF5A/KLC1 motor complex is required for axon survival and is impacted by KIF5A mutations that cause Charcot-Marie Tooth (CMT) disease. Moreover, therapeutic approaches that bypass the need for local translation of SFPQ-bound proteins prevent axon degeneration in CMT models. Collectively, these observations indicate that KIF5A-mediated SFPQ-RNA granule transport may be a key function disrupted in KIF5A-linked neurologic diseases and that replacing axonally translated proteins serves as a therapeutic approach to axonal degenerative disorders.
Skip Nav Destination
Close
Article navigation
4 January 2021
Article|
December 07 2020
Binding and transport of SFPQ-RNA granules by KIF5A/KLC1 motors promotes axon survival
Yusuke Fukuda,
Yusuke Fukuda
1
Department of Neurobiology, Harvard Medical School, Boston, MA
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Search for other works by this author on:
Maria F. Pazyra-Murphy,
Maria F. Pazyra-Murphy
1
Department of Neurobiology, Harvard Medical School, Boston, MA
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Search for other works by this author on:
Elizabeth S. Silagi,
Elizabeth S. Silagi
1
Department of Neurobiology, Harvard Medical School, Boston, MA
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Search for other works by this author on:
Ozge E. Tasdemir-Yilmaz,
Ozge E. Tasdemir-Yilmaz
1
Department of Neurobiology, Harvard Medical School, Boston, MA
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Search for other works by this author on:
Yihang Li,
Yihang Li
1
Department of Neurobiology, Harvard Medical School, Boston, MA
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Search for other works by this author on:
Lillian Rose,
Lillian Rose
1
Department of Neurobiology, Harvard Medical School, Boston, MA
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Search for other works by this author on:
Zoe C. Yeoh,
Zoe C. Yeoh
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Search for other works by this author on:
Nicholas E. Vangos,
Nicholas E. Vangos
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Search for other works by this author on:
Ezekiel A. Geffken,
Ezekiel A. Geffken
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Search for other works by this author on:
Hyuk-Soo Seo,
Hyuk-Soo Seo
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
3
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA
Search for other works by this author on:
Guillaume Adelmant,
Guillaume Adelmant
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
4
Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA
5
Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA
6
Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
Search for other works by this author on:
Gregory H. Bird,
Gregory H. Bird
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
7
Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA
8
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
Search for other works by this author on:
Loren D. Walensky,
Loren D. Walensky
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
7
Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA
8
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
Search for other works by this author on:
Jarrod A. Marto,
Jarrod A. Marto
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
4
Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA
5
Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA
6
Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
Search for other works by this author on:
Sirano Dhe-Paganon,
Sirano Dhe-Paganon
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
3
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA
Search for other works by this author on:
Rosalind A. Segal
1
Department of Neurobiology, Harvard Medical School, Boston, MA
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Correspondence to Rosalind A. Segal: rosalind_segal@dfci.harvard.edu
Search for other works by this author on:
Yusuke Fukuda
1
Department of Neurobiology, Harvard Medical School, Boston, MA
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Maria F. Pazyra-Murphy
1
Department of Neurobiology, Harvard Medical School, Boston, MA
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Elizabeth S. Silagi
1
Department of Neurobiology, Harvard Medical School, Boston, MA
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Ozge E. Tasdemir-Yilmaz
1
Department of Neurobiology, Harvard Medical School, Boston, MA
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Yihang Li
1
Department of Neurobiology, Harvard Medical School, Boston, MA
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Lillian Rose
1
Department of Neurobiology, Harvard Medical School, Boston, MA
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Zoe C. Yeoh
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Nicholas E. Vangos
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Ezekiel A. Geffken
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Hyuk-Soo Seo
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
3
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA
Guillaume Adelmant
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
4
Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA
5
Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA
6
Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
Gregory H. Bird
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
7
Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA
8
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
Loren D. Walensky
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
7
Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA
8
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
Jarrod A. Marto
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
4
Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA
5
Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA
6
Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
Sirano Dhe-Paganon
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
3
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA
Rosalind A. Segal
1
Department of Neurobiology, Harvard Medical School, Boston, MA
2
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA
Correspondence to Rosalind A. Segal: rosalind_segal@dfci.harvard.edu
Received:
May 05 2020
Revision Received:
October 15 2020
Accepted:
November 06 2020
Online Issn: 1540-8140
Print Issn: 0021-9525
Funding:
Fondation Bertarelli
(NO AWARD)
National Institutes of Health
(GM105755)
© 2020 Fukuda et al.
2020
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
J Cell Biol (2021) 220 (1): e202005051.
Article history
Received:
May 05 2020
Revision Received:
October 15 2020
Accepted:
November 06 2020
Citation
Yusuke Fukuda, Maria F. Pazyra-Murphy, Elizabeth S. Silagi, Ozge E. Tasdemir-Yilmaz, Yihang Li, Lillian Rose, Zoe C. Yeoh, Nicholas E. Vangos, Ezekiel A. Geffken, Hyuk-Soo Seo, Guillaume Adelmant, Gregory H. Bird, Loren D. Walensky, Jarrod A. Marto, Sirano Dhe-Paganon, Rosalind A. Segal; Binding and transport of SFPQ-RNA granules by KIF5A/KLC1 motors promotes axon survival. J Cell Biol 4 January 2021; 220 (1): e202005051. doi: https://doi.org/10.1083/jcb.202005051
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your Institution
615
Views
0
Citations
Advertisement
Advertisement